Brief: Peter Harwin Reports 2.32% Stake In Spyre Therapeutics As Of Dec 29 Versus Previous Stake Of 10.59% As Of Dec 7
29/12/2023 23:00
Dec 29 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* PETER HARWIN REPORTS 2.32% STAKE IN SPYRE THERAPEUTICS INC
AS OF
DEC 29 VERSUS PREVIOUS STAKE OF 10.59% AS OF DEC 7- SEC FILING
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock